Rolf Müller

Title: Rolf Müller: Innovator in Cell Cycle Regulation

Introduction

Rolf Müller is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of molecular biology, particularly in the area of cell cycle regulation. His innovative work has implications for understanding and potentially treating uncontrolled cell proliferation.

Latest Patents

Rolf Müller holds a patent for "Transcription factor E2F DNA-binding domain inhibitor peptides and their use." This invention provides peptides that bind to the DNA binding domain of transcription factor E2F, effectively inhibiting cell cycle progression. The peptides include sequences such as FWLRFT (SEQ ID NO:1), WVRWHF (SEQ ID NO:2), WHFIFW (SEQ ID NO:3), IWLSGLSRGVWVSFP (SEQ ID NO:4), and GSRILTFRSGSWYAS (SEQ ID NO:5), along with derivatives based on these sequences. The compositions and applications of these peptides are crucial for addressing issues related to uncontrolled cell proliferation.

Career Highlights

Throughout his career, Rolf Müller has worked with various organizations, including Topotarget UK Limited and Affitech Research AS. His experience in these companies has allowed him to collaborate with other experts in the field and contribute to significant advancements in biotechnology.

Collaborations

Rolf Müller has collaborated with notable colleagues such as Roland E. Kontermann and Silvia Montigiani. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Rolf Müller is a distinguished inventor whose work on transcription factor E2F inhibitor peptides represents a significant advancement in the understanding of cell cycle regulation. His contributions continue to influence the field of molecular biology and hold promise for future therapeutic applications.